Unanue E R
Immunol Rev. 1978;40:227-55. doi: 10.1111/j.1600-065x.1978.tb00408.x.
Macrophages may exert a regulatory influence at various stages in the life of the lymphocyte - they may influence the non-antigen-driven differentiation of lymphocytes - as exemplified by the effects on thymic differentiation; they may establish the mode and form of antigen to be presented or recognized by the lymphocyte; may regulate the lymphocyte's antigen-driven functions. Each of these critical regulatory steps needs explaining in molecular terms and integrated and placed in the context of the other regulatory functions of lymphocytes. The control of secretion of MP is an eloquent example of the molecular complexities and the intricate congrol mechanisms - internal and external - operating at each step of each regulatory process. A final comment concern the question of macrophage heterogeneity. Is the same cell performing all the functions of degradation, presentation, and secretion - or cytotoxicity? Or do we have subpopulation, each with a different role? This issue is not settled. The unitarians argue that the phagocytes pass through different stages of differentiation and that each function may become more or less prominent at each stage. Certainly, the manner in which each macrophage function is assayed can condition the outcome: for antigen presentation, one adds 1 % of macrophages to cultures of spleen cells; for cytotoxic assays, the figure is 50 to 100 macrophages per tumor cell! It is our feeling that until such time as membrane molecules are identified and used as probes for differentiation or for identification of subsets we will not resolve this issue. Along these lines, macrophages have been found to have Ia antigens (Hämmerling et al. 1975, Schwartz et al. 1976) and can be divided into two sets on the basis of the presence or absence of Ia. Dorf and I have found - by cytotoxicity - that only about 35 to 50% of peritoneal macrophages bear Ia molecules (Dorf & Uanue 1977). Exceptionally, some exudates will bear up to 75% positive cells. Neither Ia-positive nor Ia-negative macrophages change significantly after prolonged periods of culture. Whether these results indicate two defined subsets of macrophages is now being investigated.
巨噬细胞可能在淋巴细胞生命的各个阶段发挥调节作用——它们可能影响淋巴细胞的非抗原驱动分化,如对胸腺分化的影响所示;它们可以确定淋巴细胞呈递或识别的抗原的模式和形式;可以调节淋巴细胞的抗原驱动功能。这些关键调节步骤中的每一个都需要从分子角度进行解释,并与淋巴细胞的其他调节功能整合并置于相应背景中。MP分泌的控制是分子复杂性以及在每个调节过程的每个步骤中起作用的内部和外部复杂控制机制的一个有力例子。最后一点涉及巨噬细胞异质性的问题。是同一个细胞执行所有降解、呈递、分泌或细胞毒性功能吗?还是我们有亚群,每个亚群都有不同的作用?这个问题尚未解决。一元论者认为吞噬细胞经历不同的分化阶段,并且每个功能在每个阶段可能或多或少地突出。当然,检测每个巨噬细胞功能的方式会影响结果:对于抗原呈递,向脾细胞培养物中加入1%的巨噬细胞;对于细胞毒性检测,这个数字是每个肿瘤细胞50到100个巨噬细胞!我们的感觉是,在确定膜分子并将其用作分化或亚群识别的探针之前,我们无法解决这个问题。沿着这些思路,已发现巨噬细胞具有Ia抗原(哈默林等人,1975年;施瓦茨等人,1976年),并且可以根据Ia的有无分为两组。我和多夫通过细胞毒性发现,只有约35%至50%的腹腔巨噬细胞带有Ia分子(多夫和乌阿努埃,1977年)。例外的是,一些渗出液中阳性细胞可达75%。长时间培养后,Ia阳性和Ia阴性巨噬细胞均无明显变化。这些结果是否表明巨噬细胞有两个明确的亚群,目前正在研究中。